Clinical trial
Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension
NCT03401476 is registered in ClinicalTrials.gov with John Granton as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension
- Lead sponsor
- John Granton
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- May 8, 2017
- Completion date
- December 31, 2019
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.